CIK 0001566044
- Non-accelerated filer
- Smaller reporting company
Yarrow Bioscience, Inc.
Sign in to watch- Ticker
- YARW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453757789
- Phone
- +1 203-433-7577
- Business address
- 470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
- Former names
- VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
- 4 Shares withheld for taxes President and CEO gave up 2,734 shares (to pay taxes)
- 4 Open-market buy Director bought 20,000 shares at $2.48 ($49,680)
- 4 Open-market buy Chief Legal Officer and GC bought 10,000 shares at $2.50 ($25,000)
- 4 Shares withheld for taxes Chief Legal Officer and GC gave up 1,813 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 1,720 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 354 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 10,685 shares (to pay taxes)
- 4 Grant or award President and CEO acquired 34,705 shares (grant or award)
- 4 Shares withheld for taxes CFO gave up 353 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 1,719 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer and GC gave up 1,813 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 10,683 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes CFO gave up 354 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 1,719 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer and GC gave up 1,813 shares (to pay taxes)
Page 7 of 17 · 330 filings